USAGES THÉRAPEUTIQUES D'EMPAGLIFLOZINE
- 专利权人:
- Boehringer Ingelheim International GmbH
- 发明人:
- 申请号：
- EP14715578.2
- 公开号：
- EP2981271B1
- 申请日:
- 2014.04.03
- 申请国别(地区):
- EP
- 年份:
- 2018
- 代理人:
- 摘要：
- The present invention relates to certain SGLT-2 inhibitors for treating and/or preventing metabolic disorders, such as type 1 or type 2 diabetes mellitus or pre-diabetes, in patients with renal impairment or chronic kidney disease (CKD).
- 来源网站：
- 中国工程科技知识中心
